Evidence map›Paper›PMID 21072579›Full record

ArticleCancer causes & control : CCC2011

Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO).

Paolo Boffetta, Vijayvel Jayaprakash, Ping Yang, Kofi Asomaning, Joshua E Muscat, Ann G Schwartz, Zuo-Feng Zhang, Loic Le Marchand, Michele L Cote, Shawn M Stoddard and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS).Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2012
    Article
  12. Polonium and lung cancer.Journal of oncology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 2 countries.

Paolo BoffettaThe Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA. paolo.boffetta@i-pri.org
Vijayvel Jayaprakash
Ping Yang
Kofi Asomaning
Joshua E Muscat
Ann G Schwartz
Zuo-Feng Zhang
Loic Le Marchand
Michele L Cote
Shawn M Stoddard
Hal Morgenstern
Rayjean J Hung
David C Christiani
Mayo Clinic in Arizona · USHarvard University · USIcahn School of Medicine at Mount Sinai · USMount Sinai Hospital · CAPennsylvania State University · USRoswell Park Comprehensive Cancer Center · USThe Barbara Ann Karmanos Cancer Institute · USUCLA Health · USUniversity of Hawaiʻi at Mānoa · USUniversity of Michigan–Ann Arbor · USWayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer · 1985 to 2026
$68.4M
SCIENTIFIC INFORMATION FACILITYP30CA017613 · NCI · INSTITUTE FOR CANCER PREVENTION · PI NIXON, DANIEL W · 1985 to 2005
$13.1M
UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
GENETIC EPIDEMIOLOGY OF LUNG CANCERR01CA060691 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · 1995 to 2009
$6.2M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
ALPHA 1 AD CARRIERS AND LUNG CANCER RISKR01CA080127 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2000 to 2009
$4.4M
Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
Adenocarinoma of the Lung in WomenR01CA087895 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G · 2001 to 2005
$3.0M
Stem Cell Selection &Expansion Via HOX Gene ActivationR01CA090833 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EMERSON, STEPHEN G · 2001 to 2010
$2.6M
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERSR01DA011386 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORGENSTERN, HAL M · 1999 to 2003
$1.8M
NCI NIH HHS CA-17613NCI NIH HHS CA-29580NCI NIH HHS CA-68384NCI NIH HHS N01 PC035145NCI NIH HHS NIH CA-32617NCI NIH HHS NIH-CA 77118NCI NIH HHS NIH-CA 80127NCI NIH HHS NIH-CA 84354NCI NIH HHS P01 CA068384NCI NIH HHS P20 CA090578NCI NIH HHS P20CA090578NCI NIH HHS P30 CA017613NCI NIH HHS P30 CA022453NCI NIH HHS P30CA22453NCI NIH HHS R01 CA060691NCI NIH HHS R01 CA074386NCI NIH HHS R01CA074386NCI NIH HHS R01 CA080127NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA087895NCI NIH HHS R01 CA090833NCI NIH HHS R01 CA092824NCI NIH HHS R01CA092824NCI NIH HHS R01CA55874NCI NIH HHS R01CA60691NCI NIH HHS R01CA87895NCI NIH HHS R01CA90833NCI NIH HHS R03 CA077118NIDA NIH HHS NIH R01DA11386NIDA NIH HHS R01 DA011386
6 · The paper itself

Abstract

backgroundThe International Lung Cancer Consortium (ILCCO) was established in 2004, based on the collaboration of research groups leading large molecular epidemiology studies of lung cancer that are ongoing or have been recently completed. This framework offered the opportunity to investigate the role of tobacco smoking in the development of bronchioloalveolar carcinoma (BAC), a rare form of lung cancer.

methodsOur pooled data comprised seven case-control studies from the United States, with detailed information on tobacco smoking and histology, which contributed 799 cases of BAC and 15,859 controls. We estimated the odds ratio of BAC for tobacco smoking, using never smokers as a referent category, after adjustment for age, sex, race, and study center.

resultsThe odds ratio of BAC for ever smoking was 2.47 (95% confidence interval [CI] 2.08, 2.93); the risk increased linearly with duration, amount, and cumulative cigarette smoking and persisted long after smoking cessation. The proportion of BAC cases attributable to smoking was 0.47 (95% CI 0.39, 0.54).

conclusionsThis analysis provides a precise estimate of the risk of BAC for tobacco smoking.

Indexed as

Adenocarcinoma, Bronchiolo-AlveolarAgedCase-Control StudiesFemaleHumansLung NeoplasmsMaleMiddle AgedOdds RatioRisk FactorsSmoking

Identifiers

PMID21072579
PMCPMC3002160
OpenAlexW2125300674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.